Your browser is no longer supported. Please, upgrade your browser.
Predictive Oncology Inc.
Index- P/E- EPS (ttm)-5.41 Insider Own4.50% Shs Outstand45.50M Perf Week-17.01%
Market Cap45.60M Forward P/E- EPS next Y-0.30 Insider Trans-0.04% Shs Float16.23M Perf Month-0.81%
Income-28.70M PEG- EPS next Q-0.18 Inst Own3.80% Short Float5.38% Perf Quarter64.86%
Sales1.30M P/S35.08 EPS this Y12.90% Inst Trans225.46% Short Ratio0.20 Perf Half Y31.24%
Book/sh0.81 P/B1.51 EPS next Y- ROA-114.60% Target Price- Perf Year-47.64%
Cash/sh0.07 P/C18.24 EPS next 5Y- ROE-252.30% 52W Range0.63 - 4.42 Perf YTD66.58%
Dividend- P/FCF- EPS past 5Y58.70% ROI-145.20% 52W High-72.40% Beta2.03
Dividend %- Quick Ratio0.30 Sales past 5Y8.20% Gross Margin62.90% 52W Low93.65% ATR0.26
Employees29 Current Ratio0.30 Sales Q/Q0.00% Oper. Margin- RSI (14)42.78 Volatility21.27% 19.08%
OptionableNo Debt/Eq0.48 EPS Q/Q65.20% Profit Margin- Rel Volume1.89 Prev Close1.25
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume4.48M Price1.22
Recom- SMA20-25.86% SMA50-1.40% SMA2003.45% Volume8,375,970 Change-2.40%
Feb-24-21 08:30AM  
Feb-23-21 05:30PM  
Feb-18-21 09:00AM  
Feb-17-21 08:30AM  
Feb-16-21 05:00PM  
Feb-11-21 12:30AM  
Feb-08-21 08:30AM  
Feb-02-21 12:00PM  
Jan-28-21 08:30AM  
Jan-26-21 09:00PM  
Jan-22-21 08:00AM  
Jan-21-21 05:25PM  
Jan-19-21 08:00AM  
Jan-14-21 08:30AM  
Jan-12-21 05:15PM  
Jan-08-21 09:00AM  
Jan-06-21 08:30AM  
Jan-05-21 08:30AM  
Dec-29-20 05:15PM  
Dec-09-20 08:30AM  
Dec-02-20 08:00AM  
Nov-16-20 05:20PM  
Oct-27-20 08:30AM  
Oct-06-20 08:30AM  
Oct-02-20 12:14PM  
Sep-22-20 05:10PM  
Sep-01-20 05:15PM  
Aug-20-20 08:30AM  
Aug-18-20 08:30AM  
Aug-14-20 08:30AM  
Aug-13-20 05:10PM  
Aug-11-20 08:30AM  
Aug-05-20 09:00AM  
Jul-14-20 08:30AM  
Jul-07-20 08:15AM  
Jun-29-20 04:30PM  
Jun-18-20 08:30AM  
Jun-08-20 04:15PM  
Jun-02-20 08:30AM  
May-14-20 08:30AM  
May-07-20 08:00AM  
May-06-20 08:30AM  
Apr-22-20 05:00PM  
Apr-01-20 08:45AM  
Mar-31-20 08:30AM  
Mar-23-20 08:00AM  
Mar-16-20 09:00AM  
Mar-12-20 08:30AM  
Mar-02-20 08:30AM  
Feb-21-20 08:30AM  
Feb-07-20 02:05PM  
Feb-05-20 08:30AM  
Jan-24-20 12:30PM  
Jan-06-20 09:00AM  
Dec-17-19 08:30AM  
Dec-09-19 08:30AM  
Dec-05-19 08:30AM  
Nov-25-19 08:30AM  
Nov-20-19 08:30AM  
Nov-19-19 08:30AM  
Nov-15-19 05:10PM  
Nov-07-19 08:30AM  
Nov-06-19 08:30AM  
Oct-31-19 08:30AM  
Oct-30-19 08:30AM  
Oct-24-19 08:30AM  
Oct-02-19 09:57AM  
Oct-01-19 05:45PM  
Sep-30-19 01:00PM  
Sep-19-19 08:30AM  
Aug-19-19 08:00AM  
Aug-15-19 05:00PM  
Aug-06-19 08:00AM  
Jul-18-19 08:00AM  
Jun-26-19 08:00AM  
Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Domestic, International, and Helomics. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' exposure to infectious fluids collected during surgical and other patient procedures, as well as provides proprietary cleaning fluid and filters for use with STREAMWAY System. The company also provides data and artificial intelligence (AI) driven contract research organization (CRO) services for clinical and translational research; a range of multi-omics assays; and AI driven predictive models for the discovery of targeted therapies. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was founded in 2002 and is based in Eagan, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schwartz Carl I.Chief Executive OfficerOct 22Sale0.856405441,611,341Oct 26 05:38 PM
GABRIEL RICHARD LDirectorSep 01Buy0.904,0003,60212,070Sep 02 03:52 PM
GABRIEL RICHARD LDirectorAug 19Buy1.183,0003,5278,070Aug 21 04:09 PM